Skip to content
FrontierPicks

Covered

UROY · Uranium Royalty

Conviction · Low · more likely to lag the S&P 500 over the next three months

Wrong if: a daily close above $3.70

Picks and shovels Catalyst · Dormant theme: Nuclear & uranium

Note written ·

Price against the kill line

24.9% clear of its kill line on the 13 November 2026 close.

How to read this

This note expects the shares to lag the market, so its kill line sits above the price: a close above the red mark would prove the view wrong. Prices run from low on the left to high on the right. The dot is where the stock closed on 13 November 2026, left of the mark while it is below the line; a dot right of the mark has closed through it.

The scale is stretched near the line, so close calls are easy to see. More than 8% from the line, the stock reads well clear, with a hollow dot to show the figure is off the drawn scale.

The kill line is the research note's own test. The portfolio sells on business facts, not on a price. How the portfolio decides

UROYUranium Royalty
$3.70
$2.78
24.9%well clear

Three months against the kill line

UROY daily closes from 17 August 2026 to 13 November 2026, last $2.78, against its kill line: a daily close above $3.70. 17 August 2026: $4.1618 August 2026: $4.0419 August 2026: $4.1920 August 2026: $4.1621 August 2026: $4.3824 August 2026: $4.3725 August 2026: $4.4326 August 2026: $4.2427 August 2026: $4.3328 August 2026: $4.2631 August 2026: $4.211 September 2026: $4.142 September 2026: $4.293 September 2026: $4.444 September 2026: $4.448 September 2026: $4.829 September 2026: $4.8010 September 2026: $4.5011 September 2026: $4.3614 September 2026: $4.2415 September 2026: $4.2816 September 2026: $4.3917 September 2026: $4.4818 September 2026: $4.5621 September 2026: $4.2422 September 2026: $4.5123 September 2026: $4.4224 September 2026: $4.2525 September 2026: $4.1428 September 2026: $4.0029 September 2026: $4.0830 September 2026: $4.041 October 2026: $3.882 October 2026: $3.975 October 2026: $4.076 October 2026: $4.247 October 2026: $4.198 October 2026: $4.069 October 2026: $4.1812 October 2026: $3.9913 October 2026: $3.8814 October 2026: $3.7415 October 2026: $3.7116 October 2026: $3.5419 October 2026: $3.5020 October 2026: $3.4821 October 2026: $3.4222 October 2026: $3.3823 October 2026: $3.4326 October 2026: $3.4027 October 2026: $3.7028 October 2026: $3.5729 October 2026: $3.4730 October 2026: $3.352 November 2026: $3.253 November 2026: $3.224 November 2026: $3.135 November 2026: $2.816 November 2026: $3.049 November 2026: $3.0810 November 2026: $2.9611 November 2026: $2.9812 November 2026: $2.8213 November 2026: $2.78

Daily closes, to . Red: the kill line, a daily close above $3.70, on record since 11 November 2026. The shares are down 33.2% since the close; the S&P 500 is down 2.1% over the same sessions. Figures in the note can cover a different window.

Kill line

A daily close above $3.70, which sits over the 200-day average of closes and would show the shares leading the S&P 500 again. A second-quarter report with royalties, not inventory sales, as most operating cash flow and the bridge repaid would also show the case working.

Research onlyNot in the portfolio.

Catalyst

The portfolio's record →

Key figures from the filings · Financials

Quarter to 31 July 2026, filed 14 September 2026

Revenue, latest quarter ($M)
51.0
Revenue, change on a year (%)
+110.2
Gross margin (%)
33.1
Operating margin (%)
32.2
Net cash, cash less debt ($M)
−539
All filed numbers

What Uranium Royalty reports to the SEC in its quarterly and annual filings. Each group states its period and filing date once; a figure dated otherwise says so. Built from the filings known on .

Results by quarter Each quarter with the day its figures were first filed, and the day of a later filing that changed them
Quarter to Revenue ($M) On a year (%) Gross margin (%) Operating margin (%)
first filed 51.0 +110.2 33.1 32.2
first filed 24.2 — 16.0 9.3
Income Quarter to 31 July 2026, filed 14 September 2026
Pre-tax income ($M) 23.1
Net income ($M) 16.2
Diluted shares, change on a year (%) against the quarter to 31 July 2025 +17.7
Cash flow
Operating cash flow ($M) Not available
Capital spending ($M) Not reported
Free cash flow ($M) Not available
Balance sheet At 31 July 2026, filed 14 September 2026
Cash and short-term investments ($M) 54.1
Debt ($M) non-current long-term debt plus current maturities plus short-term borrowings 593
Net cash, cash less debt ($M) −539
Deferred revenue ($M) 0.8
Backlog, orders not yet delivered ($M) Not reported
Receivables ($M) 4.2
Inventory ($M) 0.2
Shareholders' equity ($M) 962
Valuation
Market value ($M) Not available
Enterprise value, market value plus net debt ($M) Not available
Enterprise value to sales (×) Not available
Enterprise value to operating income (×) Not available
Price to earnings (×) Not available
Price to book value (×) Not available
Free-cash-flow yield (%) Not available

Short interest (FINRA, settled 15 October 2026, published 26 October 2026): the share of shares outstanding is not available, 4.9 days of average trading to cover, +15.9% since the previous report.

Insiders' open-market trades SEC Form 4, by trade date, to
Window Bought Sold
90 daysfrom $0 $0
12 monthsfrom $43K $0

The thesis

Uranium Royalty Corp. owns royalties on uranium mines, and the shares are more likely to lag the S&P 500 over the next three months. Reported earnings came from one-off uranium-inventory sales, and a $40.0 million bridge loan falls due 31 January 2027. The fiscal second-quarter report, expected around mid-December 2026, shows whether a full quarter of Sweetwater royalty revenue changes that.

The shares closed at $2.82 on 12 November 2026, 48.9% below the 52-week high of $5.52 (intraday, 28 January 2026). The 3-month change is −31.6%. The close sits under both the 50-day average of $3.85 and the 200-day average of $3.69 (adjusted daily closes, 12 November 2026). The 52-week closing low is $2.61, set on 16 July 2026.

The Form 10-Q filed 14 September 2026 recorded $0.6 million of Sweetwater royalty revenue for 27 July through 31 July and $53.0 million of operating cash flow for the quarter ended 31 July 2026, primarily from inventory sales. The company's 27 July 2026 announcement of the Sweetwater close says the bridge was drawn under a Bank of Montreal facility. It also says a revolving facility maturing 31 July 2029 can be drawn subject to conditions that include repaying the bridge. That gives the company a stated refinancing route. No company release or filing has appeared since the 10-Q.

A second-quarter report in which royalties carry most of operating cash flow and the bridge is repaid would weaken this call. A second inventory-led quarter with the bridge still open would support it.

Bullish and bearish views on Uranium Royalty Corp.

The bull case on Uranium Royalty Corp. (UROY), in brief: acquired royalties now report revenue. The bear case: the decline has continued.

Bull case

  • Acquired royalties now report revenue. The Form 10-Q filed 14 September 2026 showed $0.6 million of Sweetwater royalty revenue from the 27 July 2026 close through 31 July, inside $0.682 million of total royalty revenue. Five days is too small a sample to support a run-rate claim.
  • A refinancing route exists. The company's 27 July 2026 announcement describes a revolving facility maturing 31 July 2029 with a margin of 1.25% to 3.75% a year, available once the bridge is repaid. Drawing it is conditional, so the route is not yet used.
  • Cash exceeded the bridge principal. At 31 July 2026 the company held $54.10 million of cash against $40.0 million of bridge principal (Form 10-Q, 14 September 2026). The cash came largely from inventory sales that do not recur on a fixed schedule.
  • An analyst target sits above the price. HC Wainwright & Co. reiterated Buy and a $4.5 price target on 19 October 2026, against the $2.82 close on 12 November 2026. The target is one firm's view.
  • A strategic holder is on the register. A Schedule 13D reported by Benzinga on 28 July 2026 showed Uranium Energy Corp. holding 7.7% as of 27 July 2026.

Bear case

  • The decline has continued. The close fell from $4.18 on 9 October 2026 to $3.38 on 22 October 2026, then to $3.04 on 6 November 2026 and $2.82 on 12 November 2026. No company filing or news release in that window explains it.
  • Earnings are inventory-led. The quarter ended 31 July 2026 included $50.967 million of uranium-inventory sales against $0.682 million of royalty revenue (Form 10-Q, 14 September 2026). The reported $0.10 diluted earnings per share reflects those sales, not steady royalty cash flow.
  • The financing clock is explicit. The filing shows a $17.25 million working-capital deficit at 31 July 2026 and a $40.0 million bridge due 31 January 2027. It also directs net equity-issuance proceeds raised before repayment toward that loan.
  • Management flagged going-concern doubt. The same filing says management's liquidity plans did not alleviate substantial doubt about the company's ability to continue as a going concern.
  • The share count rose sharply. The 27 July 2026 Sweetwater transaction issued 223,252,749 common shares to the acquired business's investors (Form 10-Q, 14 September 2026). Those holders are a source of potential selling.

Price setup

The shares closed at $2.82 on 12 November 2026, down from $3.08 on 9 November 2026, and have held above the 52-week closing low of $2.61 from 16 July 2026. A close of $2.81 on 5 November 2026 shows the shares tested this area a week earlier.

The 50-day average of closes is $3.85 and the 200-day average is $3.69, both above the last close. The 50-day average sits above the 200-day average, but the price is below both. The shares closed at $4.18 on 9 October 2026 and have not closed above $3.40 since 22 October 2026.

The observable overhang is the 223,252,749 shares issued in July and the equity-issuance clause tied to the bridge. No insider sales appear in SEC filings since the 10-Q. The second-quarter report is expected about five weeks out.

Catalysts ahead

  • ~15 December 2026 (est.): Fiscal 2027 second-quarter Form 10-Q (quarter ended 31 October 2026). Shows the first full quarter of acquired royalty revenue and how the bridge loan is being addressed.
  • 31 January 2027: Bridge-loan maturity. The first-quarter filing says $40.0 million of principal must be repaid; repayment or refinancing decides the acquisition financing case.

What would change the view

A daily close above $3.70, which sits over the 200-day average of closes and would show the shares leading the S&P 500 again. A second-quarter report with royalties, not inventory sales, as most operating cash flow and the bridge repaid would also show the case working.

What it trades with

The shares trade with uranium equities and the long-term uranium price, because the value of royalty interests follows the term-price outlook. Royalty receipts are episodic, so quarterly revenue moves with operator deliveries more than with spot prices. Uranium Energy Corp.'s 7.7% stake as of 27 July 2026 ties sentiment partly to that company's disclosures. The shares trade on NASDAQ only since the TSX listing ended on 28 July 2026.

The evidence, claim by claim (8)
  1. Quarter ended 31 July 2026 included $0.6 million of Sweetwater royalty revenue for 27 July through 31 July, within $0.682 million of total royalty revenue. Fiscal 2027 first-quarter Form 10-Q, filed 14 September 2026 · as of
  2. Quarter ended 31 July 2026 recorded $50.967 million of uranium-inventory sales and $53.0 million of operating cash flow, primarily from those sales. Fiscal 2027 first-quarter Form 10-Q, filed 14 September 2026 · as of
  3. Cash was $54.10 million, the working-capital deficit was $17.25 million and bridge principal outstanding was $40.0 million. Fiscal 2027 first-quarter Form 10-Q, filed 14 September 2026 · as of
  4. Management concluded its liquidity plans did not alleviate substantial doubt about the company's ability to continue as a going concern. Fiscal 2027 first-quarter Form 10-Q, filed 14 September 2026 · as of
  5. The US$40 million bridge was drawn under a Bank of Montreal facility and matures 31 January 2027; a revolving facility maturing 31 July 2029 is available subject to conditions including bridge repayment. Company announcement of Sweetwater close, 27 July 2026 (Barchart) · as of
  6. The Sweetwater transaction issued 223,252,749 common shares to the acquired business's investors. Fiscal 2027 first-quarter Form 10-Q, filed 14 September 2026 · as of
  7. HC Wainwright & Co. reiterated a Buy rating with a $4.5 price target. HC Wainwright & Co. note, reported 19 October 2026 · as of
  8. The shares closed at $2.82 on 12 November 2026, below the 50-day average of $3.85 and the 200-day average of $3.69; the 3-month change was −31.6%. Adjusted daily closes · as of

Sources

Related · shared themes

Every buy and sale, with its reason, is published in the portfolio feed. Follow the portfolio feed → Follow @frontierpicks on X